C1q Produkte
(Complement Fragment C1q (C1q))
Kategorien
C1q associates with the proenzymes C1r and C1s to yield C1, the first component of the serum complement system. The collagen-like regions of C1q interact with the Ca(2+)-dependent C1r(2)C1s(2) proenzyme complex, and efficient activation of C1 takes place on interaction of the globular heads of C1q with the Fc regions of IgG or IgM antibody present in immune complexes.
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte C1q Kategorien
C1q Antikörper
High quality antibodies with extensive validation data.
C1q ELISA Kits
Reliable ELISA kits for a wide range of species.
C1q Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene C1q Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
IHC (fro)
Validierungen
- (3)
Kat. Nr.
ABIN2477784
Menge
1 mL
Datenblatt
Datenblatt
Reaktivität
Mouse
Applikation
FACS, IHC (fro), IF, Func
Validierungen
- (3)
Kat. Nr.
ABIN2191846
Menge
50 μg
Datenblatt
Datenblatt
Reaktivität
Mouse
Applikation
FACS, IA
Validierungen
- (5)
Kat. Nr.
ABIN2191787
Menge
100 μg
Datenblatt
Datenblatt
Empfohlene C1q ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (3)
- (1)
Kat. Nr.
ABIN6955043
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Monkey
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6963095
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Mouse
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6999543
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene C1q Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Neueste Publikationen zu unseren C1q Produkten
: "CXCL4 suppresses tolerogenic immune signature of monocyte-derived dendritic cells." in: European journal of immunology, Vol. 50, Issue 10, pp. 1598-1601, (2021) (PubMed).: "Complement activation profile of patients with primary focal segmental glomerulosclerosis." in: PLoS ONE, Vol. 15, Issue 6, pp. e0234934, (2020) (PubMed).
: "The role of complement components C1q, MBL and C1 inhibitor in pathogenesis of endometriosis." in: Archives of gynecology and obstetrics, Vol. 297, Issue 6, pp. 1495-1501, (2018) (PubMed).
: "Acute and prolonged complement activation in the central nervous system during herpes simplex encephalitis." in: Journal of neuroimmunology, Vol. 295-296, pp. 130-8, (2016) (PubMed).
: "Complement activation contributes to the injury and outcome of kidney in human anti-glomerular basement membrane disease." in: Journal of clinical immunology, Vol. 33, Issue 1, pp. 172-8, (2013) (PubMed).
: "Selectivity analysis of single binder assays used in plasma protein profiling." in: Proteomics, Vol. 13, Issue 23-24, pp. 3406-10, (2013) (PubMed).
: "Variance decomposition of protein profiles from antibody arrays using a longitudinal twin model." in: Proteome science, Vol. 9, pp. 73, (2011) (PubMed).
: "Complement protein C1q forms a complex with cytotoxic prion protein oligomers." in: The Journal of biological chemistry, Vol. 285, Issue 25, pp. 19267-76, (2010) (PubMed).
: "Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage." in: The American journal of pathology, Vol. 176, Issue 4, pp. 1648-59, (2010) (PubMed).
: "B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice." in: The Journal of clinical investigation, Vol. 119, Issue 10, pp. 2990-9, (2009) (PubMed).
Synonyme und alternative Namen zu C1q
complement component 1, q subcomponent, alpha polypeptide (C1qa), AI255395, C1qBezeichner auf Proteinebene für C1q
- complement C1q subcomponent subunit A
Sie sind hier:
